The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New ÒÁÈ˾þà articles
1
A new tectonic plate boundary could be forming in southern Africa
2
First test of CO2 removal with green sand finds no harm to marine life
3
Why autism pioneer Uta Frith wants to dismantle the spectrum
4
Neanderthals treated a dental cavity by drilling into the tooth
5
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
6
Rebooting stem cells builds aged muscles and assists injury recovery
7
SpaceX is about to launch tallest and most powerful rocket in history
8
Where did the laws of physics come from? I think I've found the answer
9
CAR T-cell therapy bolstered by stiffening up cancer cells first
10
Arctic fires are releasing carbon stored for thousands of years
